AWP
AZN icon

Axis Wealth Partners’s AstraZeneca AZN Stock Holding History

Axis Wealth Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$367K Sell
1,936
-34
-2% -$6.39K 0.18% 128
2026
Q1 		$389K Sell
1,970
-46
-2% -$8.87K 0.21% 121
2025
Q4 		$371K Buy
2,016
+15
+0.7% +$2.63K 0.2% 122
2025
Q3 		$307K Sell
2,001
-32
-2% -$4.84K 0.18% 121
2025
Q2 		$284K Hold
2,033
– – 0.19% 119
2025
Q1 		$299K Sell
2,033
-23
-1% -$3.33K 0.22% 111
2024
Q4 		$269K Buy
+2,056
New +$288K 0.23% 114

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Axis Wealth Partners's AZN Position: Q2 2026 in Review

Axis Wealth Partners reduced its AstraZeneca (AZN) stake by 1.7% in Q2 2026, selling an estimated $6.39K and leaving 1,936 shares worth $367K. The position accounts for 0.18% of the portfolio, ranked #128.

Axis Wealth Partners first reported a position in AZN in Q4 2024 and has held it in 7 quarters since. The position peaked at $389K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Axis Wealth Partners held 1,936 shares of AstraZeneca worth $367K as of Q2 2026.
  • Axis Wealth Partners sold 34 AstraZeneca shares in Q2 2026, an estimated $6.39K.
  • AstraZeneca made up 0.18% of Axis Wealth Partners's portfolio in Q2 2026, its #128 holding.
  • Axis Wealth Partners first reported a position in AstraZeneca in Q4 2024 and has held it in 7 quarters since.
  • Axis Wealth Partners's AstraZeneca position peaked at $389K in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Axis Wealth Partners's 13F filing for Q2 2026, filed 28 Jul 2026.